Blocking TREM-1 with LR12, a TREM-1 antagonist peptide, has shown a significant protective effect on LPS-induced acute lung injury via inhibiting the activation of the NLRP3 inflammasome (Liu et al., 2016). Here, NLRP3 is linked to injury.